Heart Disease Journals

Cardiology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Burgess DC et al. – Silent and clinical MI have similar risk factors and increase the risk of future CVD events. Fenofibrate reduces the risk of a first MI and substantially reduces the risk of further clinical CVD events after silent MI, supporting its use in type 2 diabetes.

Related Articles

Comparison of Incidence of Acute Myocardial Infarction in Patients With Type 2 Diabetes Mellitus Following Initiation of Neutral Protamine Hagedorn Insulin Versus Insulin Glargine
The American Journal of Cardiology, 10/01/09    Relevance Score: 97%

Pioglitazone Compared with Metformin Increases Pericardial Fat Volume in Patients with Type 2 Diabetes Mellitus
Journal of Clinical Endocrinology and Metabolism, 11/18/09    Relevance Score: 93%

Left Ventricular Diastolic Function in Type 2 Diabetes Mellitus: Prevalence and Association with Myocardial and Vascular Disease
Circulation: Cardiovascular Imaging, 10/27/09    Relevance Score: 93%

Abnormal myocardial insulin signalling in type 2 diabetes and left-ventricular dysfunction
European Heart Journal, 10/02/09    Relevance Score: 93%

Review: diabetes is not a coronary disease equivalent
Evidence-Based Medicine, 10/06/09    Relevance Score: 92%


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address